Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Pene Dumitrescu, T"'
Autor:
Chandasana H; Clinical Pharmacology Modeling & Simulation, GSK, Collegeville, Pennsylvania, USA., Singh R; Clinical Pharmacology Modeling & Simulation, GSK, Collegeville, Pennsylvania, USA., Adkison K; ViiV Healthcare, Durham, North Carolina, USA., Ait-Khaled M; ViiV Healthcare Ltd., Brentford, United Kingdom., Pene Dumitrescu T; Clinical Pharmacology Modeling & Simulation, GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 May 02; Vol. 68 (5), pp. e0150423. Date of Electronic Publication: 2024 Apr 08.
Autor:
Pene Dumitrescu, T1, Santos, LL2, Hughes, SC3, Pereira, AI3, Young, GC3, Hussey, E2, Charlton, P2, Baptiste‐Brown, S4, Stuart, JS2, Vincent, V5, Marle, SP6, Schmith, VD1
Publikováno v:
CTS: Clinical & Translational Science. Aug2016, Vol. 9 Issue 4, p183-191. 9p.
Autor:
Johnson M; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Pene Dumitrescu T; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Joshi SR; ViiV Healthcare, Branford, Connecticut, USA., Mathew A; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Bainbridge V; GlaxoSmithKline, Brentford, UK., Zhan J; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Lataillade M; ViiV Healthcare, Branford, Connecticut, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 May; Vol. 11 (5), pp. 632-639. Date of Electronic Publication: 2022 Jan 07.
Autor:
Pene Dumitrescu T; GlaxoSmithKline, Collegeville, PA, USA., Greene TJ; GlaxoSmithKline, Collegeville, PA, USA., Joshi SR; ViiV Healthcare, Branford, CT, USA., Xu J; GlaxoSmithKline, Collegeville, PA, USA., Johnson M; ViiV Healthcare, Research Triangle Park, NC, USA., Halliday F; GlaxoSmithKline, Uxbridge, UK., Butcher L; GlaxoSmithKline, Collegeville, PA, USA., Zimmerman E; PPD, Richmond, VA, USA., Webster L; PPD, Richmond, VA, USA., Pham TT; PPD, Austin, TX, USA., Lataillade M; ViiV Healthcare, Branford, CT, USA., Min S; ViiV Healthcare, Research Triangle Park, NC, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Feb; Vol. 88 (4), pp. 1704-1712. Date of Electronic Publication: 2021 Sep 21.
Autor:
Pene Dumitrescu T; GlaxoSmithKline, Collegeville, PA, USA., Joshi SR; ViiV Healthcare, Branford, CT, USA., Xu J; GlaxoSmithKline, Collegeville, PA, USA., Greene TJ; GlaxoSmithKline, Collegeville, PA, USA., Johnson M; ViiV Healthcare, Research Triangle Park, NC, USA., Butcher L; GlaxoSmithKline, Collegeville, PA, USA., Zimmerman E; PPD, Richmond, VA, USA., Webster L; PPD, Richmond, VA, USA., Pham TT; PPD, Austin, TX, USA., Lataillade M; ViiV Healthcare, Branford, CT, USA., Min S; ViiV Healthcare, Research Triangle Park, NC, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Sep; Vol. 87 (9), pp. 3501-3507. Date of Electronic Publication: 2021 Mar 04.
Autor:
Nasir, A., Bissonnette, R., Maari, C., DuBois, J., Pene Dumitrescu, T., Haddad, J., Yamaguchi, Y., Dalessandro, M.
Publikováno v:
Journal of the European Academy of Dermatology & Venereology; Jan2018, Vol. 32 Issue 1, p145-151, 7p
Publikováno v:
Oncogene. 11/27/2008, Vol. 27 Issue 56, p7055-7069. 15p. 1 Diagram, 1 Chart, 9 Graphs.
Autor:
Pene Dumitrescu T; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Joshi SR; ViiV Healthcare, Branford, Connecticut, USA., Xu J; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Zhan J; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Johnson M; ViiV Healthcare, Research Triangle Park, North Carolina, USA mark.a.johnson@viivhealthcare.com., Butcher L; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Zimmerman E; PPD, Richmond, Virginia, USA., Webster L; PPD, Richmond, Virginia, USA., Davidson AM; PPD, Austin, Texas, USA., Lataillade M; ViiV Healthcare, Branford, Connecticut, USA., Min S; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 May 18; Vol. 65 (6). Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Autor:
Yap TA; Drug Development Unit, Royal Marsden Hospital, London, England, United Kingdom., Winter JN; Medicine (Hematology and Oncology), Robert H. Lurie Comprehensive Cancer Center and Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Giulino-Roth L; Departments of Pediatrics and Medicine and Laboratory Medicine, Weill Cornell Medical College, New York, New York., Longley J; Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom., Lopez J; Consultant Medical Oncologist, Institute of Cancer Research, Royal Marsden, London, United Kingdom., Michot JM; Department of Hematology and Innovative Drugs, Institut Gustave Roussy, France., Leonard JP; Departments of Pediatrics and Medicine and Laboratory Medicine, Weill Cornell Medical College, New York, New York., Ribrag V; Department of Hematology and Innovative Drugs, Institut Gustave Roussy, France., McCabe MT; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Creasy CL; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Stern M; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Pene Dumitrescu T; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Wang X; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Frey S; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Carver J; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Horner T; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Oh C; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Khaled A; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Dhar A; Research and Development, GlaxoSmithKline, Collegeville, Pennsylvania., Johnson PWM; Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom. johnsonp@soton.ac.uk.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 15; Vol. 25 (24), pp. 7331-7339. Date of Electronic Publication: 2019 Aug 30.
Autor:
Du, Rui1 (AUTHOR) u6034319@utah.edu, Wang, Ping1 (AUTHOR) ping.wang@utah.edu, Tian, Ning1,2,3,4 (AUTHOR) ning.tian@hsc.utah.edu
Publikováno v:
Cells (2073-4409). Jun2024, Vol. 13 Issue 12, p1006. 22p.